232 related articles for article (PubMed ID: 32109259)
1. Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
Van der Sluis RM; Zerbato JM; Rhodes JW; Pascoe RD; Solomon A; Kumar NA; Dantanarayana AI; Tennakoon S; Dufloo J; McMahon J; Chang JJ; Evans VA; Hertzog PJ; Jakobsen MR; Harman AN; Lewin SR; Cameron PU
PLoS Pathog; 2020 Feb; 16(2):e1008151. PubMed ID: 32109259
[TBL] [Abstract][Full Text] [Related]
2. The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.
Kumar NA; Cheong K; Powell DR; da Fonseca Pereira C; Anderson J; Evans VA; Lewin SR; Cameron PU
Retrovirology; 2015 Sep; 12():76. PubMed ID: 26362311
[TBL] [Abstract][Full Text] [Related]
3. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4
Kumar NA; van der Sluis RM; Mota T; Pascoe R; Evans VA; Lewin SR; Cameron PU
J Immunol; 2018 Sep; 201(5):1468-1477. PubMed ID: 30030324
[TBL] [Abstract][Full Text] [Related]
5. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
7. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
[TBL] [Abstract][Full Text] [Related]
8. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU
Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960
[TBL] [Abstract][Full Text] [Related]
9. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
Bobardt M; Kuo J; Chatterji U; Chanda S; Little SJ; Wiedemann N; Vuagniaux G; Gallay PA
PLoS One; 2019; 14(2):e0211746. PubMed ID: 30716099
[TBL] [Abstract][Full Text] [Related]
11. Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.
Evans VA; Kumar N; Filali A; Procopio FA; Yegorov O; Goulet JP; Saleh S; Haddad EK; da Fonseca Pereira C; Ellenberg PC; Sekaly RP; Cameron PU; Lewin SR
PLoS Pathog; 2013; 9(12):e1003799. PubMed ID: 24339779
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
Banga R; Procopio FA; Cavassini M; Perreau M
J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
[TBL] [Abstract][Full Text] [Related]
15. Combination Immune Checkpoint Blockade to Reverse HIV Latency.
Van der Sluis RM; Kumar NA; Pascoe RD; Zerbato JM; Evans VA; Dantanarayana AI; Anderson JL; Sékaly RP; Fromentin R; Chomont N; Cameron PU; Lewin SR
J Immunol; 2020 Mar; 204(5):1242-1254. PubMed ID: 31988180
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
17. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
18. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.
Anderson JL; Mota TM; Evans VA; Kumar N; Rezaei SD; Cheong K; Solomon A; Wightman F; Cameron PU; Lewin SR
PLoS One; 2016; 11(7):e0158778. PubMed ID: 27383184
[TBL] [Abstract][Full Text] [Related]
19. Calcium/calcineurin synergizes with prostratin to promote NF-κB dependent activation of latent HIV.
Chan JK; Bhattacharyya D; Lassen KG; Ruelas D; Greene WC
PLoS One; 2013; 8(10):e77749. PubMed ID: 24204950
[TBL] [Abstract][Full Text] [Related]
20. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.
Macedo AB; Novis CL; De Assis CM; Sorensen ES; Moszczynski P; Huang SH; Ren Y; Spivak AM; Jones RB; Planelles V; Bosque A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]